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Interleukin-25 Induces Resistance 
Against Intestinal Trematodes
Carla Muñoz-Antoli, Alba Cortés, Rebeca Santano, Javier Sotillo†, J. Guillermo Esteban & 
Rafael Toledo
Echinostoma caproni is an intestinal trematode that has been extensively used as an experimental 
model to investigate the factors determining the resistance to intestinal helminths or the development 
of chronic infections. ICR mice are permissive hosts for E. caproni in which chronic infections are 
developed, concomitantly with local Th1 responses, elevated levels of local IFN-γ, inflammation and 
antibody responses. However, mice develop partial resistance to homologous challenge infections 
after cure of a primary infection, which converts this subject into an adequate model for the study 
of the mechanisms generating resistance against intestinal helminths. The purpose of the present 
study was to compare the immune response induced in primary and secondary infections to elucidate 
the factors determining the different outcome of the infection in each type of infection. The results 
obtained indicate that susceptibility is determined by the lack of IL-25 expression in response to primary 
infection. In contrast, infection in an environment with elevated levels of IL-25, as occurs in challenge 
infection, results in a Th2 phenotype impairing parasite survival. This was confirmed by treatment of 
naïve mice with exogenous IL-25 and subsequent infection. Changes induced in goblet cell populations 
and mucin glycosylation could be implicated in resistance to infection.
Intestinal helminth infections are among the most prevalent infections and it is estimated that more than 
1.5 billion people are currently infected with one or more species of intestinal helminth mainly in Asia, Africa and 
Latin-America1,2. Notably, children experience the highest prevalences and intensities of infection in these areas 
with over 270 million preschool-age and over 600 million school-age children currently infected2. An impor-
tant number of these infections are caused by intestinal trematodes with estimates reaching 40 million people 
infected and more than 10% of the world’s population at risk of infection3–6. Commonly, intestinal helminths 
cause chronic and debilitating diseases associated with diarrhea, abdominal pain, malabsorption syndrome, vita-
min deficiencies, anemia, growth retardation and/or impaired cognitive function among other symptoms2,7–9. 
Additionally, intestinal helminths cause substantial economic losses in livestock production worldwide10,11.
Although treatment of intestinal helminth infections is in general effective, it is expensive and difficult to 
implement. Moreover, reinfections are continuous and resistant strains are emerging1. In this context, there is 
urgent need for expanding research activity on developing more effective interventions such as vaccination. 
However, a more comprehensive understanding of the parasite’s biology and the host-parasite interactions of 
these infections is required. In this context, the use of different host-parasite experimental models has been 
proven to be a useful approach to investigate the factors determining the resistance to intestinal helminths.
Echinostomes are common human parasites in East and Southeast Asia12. Moreover, echinostomes, and 
particularly Echinostoma caproni (Trematoda: Echinostomatidae), have been extensively used for the study the 
factors on which rely the establishment of chronic infections or, in contrast, the development of resistance to 
intestinal helminths. E. caproni is an intestinal trematode with no tissue phase in the vertebrate definitive host13. 
After infection, the metacercariae excyst in the duodenum and the juvenile worms migrate to the ileum, where 
they attach to the mucosa. E. caproni has a wide range of definitive hosts, although its compatibility differs con-
siderably between rodent species in terms of worm survival and development14. In mice and other hosts of high 
compatibility, the infection becomes chronic, while in hosts of low compatibility, (e.g. rats) the worms are expelled 
from the 2–4 weeks post-infection15,16. Moreover, the consequences of the infection in each host class are mark-
edly different. The establishment of chronic infections in ICR mice is dependent upon a local Th1 response with 
elevated production of IFN-γ 17. The infection induces important inflammatory responses, a marked epithelial 
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injury and a rapid increase of iNOS expression16,17. In contrast, the resistance to E. caproni infection in hosts 
of low compatibility is associated with the development of a local Th2/Th17 phenotype and changes in tissue 
structure are not observed17,18. Because of these characteristics, the E. caproni-rodent model is extensively used to 
elucidate several aspects of the host-parasite relationships in intestinal infections, such as the induction of distinct 
effector mechanisms and their effectiveness in parasite clearance.
Although mice are permissive host for E. caproni14,19, a recent study showed that primary infection in ICR 
mice induces acquired immunity against subsequent homologous infection which is manifested in reduced infec-
tion rate, worm recovery and growth20. This makes the E. caproni/ICR mouse system an excellent model for 
the study of the mechanisms generating acquired immunity against intestinal helminths. Herein, we use the 
E. caproni/mice system to analyze the regulation of immune responses against intestinal helminths and the factors 
governing the resistance against these parasites. To this purpose, we followed two approaches. We have extended 
previous studies on the responses associated to chronicity (primary infections) and compared these responses to 
those related to resistance to infection (secondary infections). In addition, we have also analyzed other immune 
mechanisms induced by primary response that have been associated with resistance against intestinal helminth 
infections.
Results
Mice develop resistance against E. caproni in secondary infections and after treatment with rIL-25. 
Mice in infected, praziquantel (pzq)-treated and reinfected groups became infected after primary exposure to 
E. caproni metacercariae. In secondary infections, however, rates of infection were significantly lower than those 
observed in primary infections (p < 0.001). Only 54% of mice belonging to the reinfected group became infected 
after secondary exposure to E. caproni metacercariae. Similarly, worm recoveries were lower in secondary than in 
primary infections (p < 0.001). In primary infections, worm recoveries at 2 and 4 weeks post-primary infection 
(wppi) ranged from 54 to 94% (76.0 ± 16.6), whereas they were between 0 and 63% (29.9 ± 26.8) at 2 and 4 weeks 
post-secondary infection (wpsi). Strikingly, mice treated with rIL-25 were refractory to primary infection with 50 
metacercariae of E. caproni and all the animals were negative at 3, 7 and 14 days post-primary infection.
Different cytokine profile is associated with susceptibility or resistance to infection. Changes in 
cytokine expression as a consequence of primary infection, drug cure and secondary infection were investigated 
by real-time PCR. The expression of almost all the cytokines studied showed alterations over the course of the 
experiment (Fig. 1). Only IL-5, IL-10, IL-23A and TGF-β remained unchanged in our study (see Supplementary 
Figure 1).
Primary infection was characterized by significant elevations of IL-6, IL-9, IL-12p35, IL-12p40, IL-33, IFN-γ 
and TSLP. However, the values of IL-12p35 and IL-12p40 decreased at 4 wppi in the three groups of mice. In the 
group of infected animals, the values of IL-6, IL-9, IL-33, IFN-γ and TSLP remained elevated until the end of the 
experiment (Fig. 1).
Figure 1. Different cytokine profile is associated with primary and secondary infections. Expression of 
cytokine mRNA in the intestinal tissue of ICR mice infected, praziquantel (pzq)-treated and reinfected with 
Echinostoma caproni. The relative quantities (RQ) of cytokine genes are shown after normalization with β -actin 
and standardization of the relative amount against day 0 sample. Vertical bars represent the standard deviation. 
a: significant differences with respect to negative controls; b: significant differences between groups at each week 
of the study (p < 0.05).
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Drug cure resulted in a sudden decrease of most of the cytokines that became overexpressed after primary 
infection (IL-6, IL-9, IL-12, IL-33, IFN-γ and TSLP). However, worm elimination induced an increase in the 
expression of IL-25 as observed both in the pzq-treated and reinfected groups from 5 wppi. In both groups the 
levels of IL-25 remained elevated until the end of the experiment (Fig. 1). Secondary infection induced a rapid 
increase in the expression of IL-4, IL-6 and IL-13 from 2 wpsi and beyond. The expression of the remainding 
cytokines, except IL-25, remained at low level (Fig. 1).
The levels of cytokines in rIL-25-treated mice are shown in Fig. 2. Treatment of mice with exogenous IL-25 
induced elevated levels of IL-4 and, mainly, IL-13. After exposure to E. caproni metacercariae, the values of these 
cytokines progressively decreased, though they remained significantly higher than in control animals until the 
end of the experiment. As occurred in primarily infected mice, an early and transient upregulation of IL-12p35 
was observed, though the values rapidly returned to normal levels. Interestingly, exogenous IL-25 induced 
marked overexpression of endogenous IL-25 that remained positive during the complete experiment. In contrast, 
IL-33 and IFN-γ were not affected by treatment with IL-25.
Primary and secondary infection induces differential activation of macrophages. To study the 
role of macrophages in the course of E. caproni primary and secondary infections and the pathology induced by the 
parasite, we have analyzed several markers of classical or M1 (ArgII and iNOS) or alternative or M2 (ArgI and Ym-1) 
activation of macrophages. Interestingly, we found that primary infection with E. caproni simultaneously induced 
overexpression of markers of M1 (iNOS) and M2 (ArgI and Ym-1) activation (Fig. 3). In the group of infected 
animals, expression levels remained significantly higher than in control animals in the most of the wppi studied, 
mainly in the case of iNOS. After drug cure, the levels of ArgI and YM-1 returned to normal values and remained 
at this level in the group of treated animals until the end of the experiment. The expression of iNOS decreased to 
normal values from 8 wppi in all the animals treated with pzq. Secondary infection resulted in a new increase of 
ArgI and Ym-1 expression, whereas the expression of iNOS was similar to control animals.
Partial and complete resistance is associated with goblet cell expansion. Primary E. caproni 
infections induced a marked goblet cell expansion from 4 wppi, reaching values of about 3-fold higher than in 
control animals. Thereafter, the counts remained elevated until the end of the experiment. Drug cure of the infec-
tion resulted in a sudden decrease of goblet cell counts, returning to normal values at 6 wppi. Secondary infection 
induced a rapid goblet cell hyperplasia at 8 wppi (2 wpsi) reaching similar values than in primary infections 
(Fig. 4A).
Treatment of naïve mice with rIL-25 induced rapid goblet cell expansion (about 3-fold higher than in control 
animals) detectable from 2 days post-treatment with rIL-25. Goblet cell hyperplasia was constant over the com-
plete course of the experiment. Infection of rIL-25-treated mice did not induce changes in goblet cell counts with 
respect to non-infected rIL-25-treated mice (Fig. 4B).
Figure 2. Treatment with rIL-25 induces a Th2 phenotype concomitantly with resistance to infection. 
Expression of cytokine mRNA in the intestinal tissue of rIL-25-treated ICR mice and rIL-25-treated and 
infected ICR mice with Echinostoma caproni. The relative quantities (RQ) of cytokine genes are shown after 
normalization with β -actin and standardization of the relative amount against day 0 sample. Vertical bars 
represent the standard deviation. a: significant differences with respect to negative controls; b: significant 
differences between groups at each week of the study (p < 0.05).
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Both E. caproni primary and secondary infection induce tuft cell expansion. As tuft cells may play 
a major role in resistance against intestinal helminths, we investigated tuft cell responses in each group of mice 
(Fig. 5). Primary E. caproni infection induced a rapid tuft cell expansion of about 8-fold greater than naïve ani-
mals (Fig. 5A,B). Tuft cell hyperplasia was detectable from 2 wppi, and the values remained at this level until the 
end of the experiment. The extent of this hyperplasia was uniform throughout the ileum. Drug cure of primary 
infection did not affect the tuft cell counts, which remained elevated. In contrast, secondary infection elicited a 
dramatic (> 30-fold higher with respect to negative controls) tuft cell hyperplasia at 2 wpsi (Fig. 5B).
Treatment of naïve mice with exogenous IL-25 also induced expansion of tuft cells (of about 37-fold greater 
than naïve mice) that peaked at the 9th day after starting the treatment with rIL-25. Exposure to metacercariae 
of rIL-25-treated mice did not alter tuft cell counts that were similar to those observed in non-infected 
rIL-25-treated mice (Fig. 5C,D).
Figure 3. Pattern of macrophage activation is different in primary and secondary infections. Expression of 
markers mRNA of both classical (Arg2 and iNOS) and alternative (ArgI and Ym-1) activation of macrophages 
in the intestinal tissue of ICR mice infected, praziquantel (pzq)-treated and reinfected with Echinostoma caproni. 
The relative quantities (RQ) of cytokine genes are shown after normalization with β -actin and standardization 
of the relative amount against day 0 sample. Vertical bars represent the standard deviation. a: significant 
differences with respect to negative controls; b: significant differences between groups at each week of the study 
(p < 0.05).
Figure 4. Infection and treatment with rIL-25 induce goblet cell expansion. Kinetics of goblet cells in (A) 
mice infected, praziquantel (pzq)-treated and reinfected with Echinostoma caproni. and (B) rIL-25-treated ICR 
mice and rIL-25-treated and infected ICR mice with Echinostoma caproni. Vertical bars represent the standard 
deviation. a: significant differences with respect to negative controls; b: significant differences between groups at 
each week of the study (p < 0.05).
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Infection with E. caproni and treatment with rIL-25 induce changes in glycosylation of mucins. 
To study alterations in the saccharide residues of mucins induced by E. caproni infections and rIL-25 treatment 
which can be associated with resistance development, four lectins with different ligand specificity were used to 
stain the ileal mucosa of mice belonging to the different groups. We have focused our analysis on the specific 
staining of brush border (transmembrane mucins), extracellular mucus (gel-forming mucins) and goblet cell 
vesicles (mucus producing cells) (Tables 1 and 2; Fig. 6).
Specific staining was undetected using WGA lectin in control animals. After primary infection, a slight 
increase in the intensity of staining was observed. The intensity of staining increased further after drug cure 
and reinfection. (Table 1; Fig. 6). Using DBA lectin, specific staining was detected in control animals. As a con-
sequence of primary infection, a slight increase was observed at 4 wppi, though drug cure induced a drastic 
decrease. The staining intensity became higher after secondary infection at 10 wppi (4 wpsi). Staining of mucus 
and goblet cell vesicles in naïve mice was detected using UEA-I. A few changes were observed after primary infec-
tion and a slight decrease was observed after secondary infection (Table 1; Fig. 6). Using SNA lectin, no significant 
changes were observed during the experiment.
Treatment of naïve mice with exogenous IL-25 only induced slight changes as compared with control animals 
using WGA, DBA and SNA lectins (Table 2). Moreover, infection of rIL-25-treated mice did not induce signifi-
cant changes with respect to naïve mice. In contrast, relevant changes were observed when using UEA-I lectin. 
A marked increase of specific staining of mucus and goblet cell vesicles was detected from 2 days post-treatment 
with rIL-25 and the intensity remained elevated until the end of the experiment. Strikingly, exposure to E. caproni 
metacercariae induced a significant decrease in the intensity of staining with this lectin (Table 2; Fig. 6).
Discussion
Contrary to what occurs with most intestinal helminths, E. caproni primary infections in ICR mice induce a local 
Th1 response with increased expression of IFN-γ 17. This response is associated with the development of chronic 
infections with elevated inflammation and tissue damage16. However, mice become resistant to homologous 
secondary infections after drug cure of a primary infection20,21. Due to these characteristics, we have used the 
E. caproni-mouse system to analyze the factors governing the regulation of immune responses against intestinal 
helminths and their consequences on the outcome of the infection. Our results support IL-25 induces resistance 
to E. caproni infection and that susceptibility to primary infection relies on the the inability of mice to express 
IL-25 in response to infection. In contrast, resistance to secondary infection appears to be related to the boost 
of IL-25 induced by the cure of the infection. These features indicate that IL-25, but not IL-33 and/or TSLP, is 
essential for resistance to infection.
Figure 5. Tuft cell hyperplasia is induced by both infection and treatment with rIL-25. Kinetics of tuft cells 
in (A,B) mice infected, praziquantel (pzq)-treated and healed from a primary infection and secondarily infected 
with Echinostoma caproni and (C,D) rIL-25-treated ICR mice and rIL-25-treated and infected ICR mice with 
Echinostoma caproni. Vertical bars represent the standard deviation. a: significant differences with respect to 
negative controls; b: significant differences between groups at each week of the study (p < 0.05). wppi: weeks 
post-primary infection; dpt: days after infection. Scale bar: 30 μ m.
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Primary E. caproni infection induced a mucosal environment consistent with a local Th1 response as described 
previously17. However, this response is much more complex than previously thought. Concomitantly with ele-
vated levels of Th1 indicators (IL-12, IFN-γ and iNOS), primary infections induced increased expression of sev-
eral Th2 markers (IL-33, TSLP, ArgI and Ym-I) and other cytokines such as IL-9. IL-33 and TSLP are alarmins 
produced by epithelial cells in response to injury and, together with IL-25, act on other innate cells (type 2 innate 
lymphoid cells or ILC2) to produce IL-4 and/or IL-13 promoting Th2 responses22–25. The increased expression 
of IL-33 and TSLP in primary E. caproni infections in mice could be expected due to the severe tissue dam-
age induced20,21. However, the lack of IL-25 overexpression was striking, especially considering that infection 
induced a marked tuft cell hyperplasia. Tuft cells constitutively express IL-25 and, after helminth infection, tuft 
cell-derived IL-25 activates ILC2 to secrete IL-13 that, via IL-4Rα signaling induces tuft cell hyperplasia and 
increased levels of IL-25 in a feed-forward circuit promoting Th2 responses against helminths26–28. E. caproni 
primary infection induced a tuft cell expansion of about 8-fold which is similar to that induced by other intestinal 
helminths such as Nippostrongylus brasiliensis, Heligmosomoides polygyrus or Trichinella spiralis26,27. However, the 
expansion of the tuft cell lineage was not accompanied by an increase in IL-25 expression in E. caproni primary 
infection. Probably, parasite-induced signals do not enhance IL-25 production by tuft cells or disrupt transduc-
tion signal pathways in these cells. These topics need to be explored further to obtain a better understanding on 
how parasites can evade host responses.
In the absence of IL-25, the early production of both subunits of IL-12 (IL-12p35 and IL-12p40) may be 
essential for the determination of the susceptibility to infection. IL-12 (or IL-12p70) is a key pro-inflammatory 
cytokine that promotes the differentiation toward a Th1 phenotype and stimulates IFN-γ production inhibiting 
the expression of IL-1329,30. Under these conditions, primary infections resulted in the development of a local Th1 
phenotype as shown by upregulation of IFN-γ and low levels of IL-4 and IL-13. This suggests that, in absence of 







Control 0 − − − NA
Infected
2 + − + /− 
− 
4 + + /− + 
Pzq-treated
5 + + + + + + NA
6 + + + + + + NA
Reinfected
8 + + + + + + NA
10 + + + + + + + + + NA
DBA
Control 0 + + + + + + NA
Infected
2 + + + + + + NA
4 + + + + + + + + + NA
Pzq-treated
5 + + /− + /− + 
6 + + + + + + /− + + 
Reinfected
8 + + + + /− − 
10 + + + + + + + + + NA
UEA-I
Control 0 − + + + NA
Infected
2 + /− + + + + + − 
4 + /− + + + + NA
Pzq-treated
5 − + /− + /− + 
6 − + /− + /− + 
Reinfected
8 − + + /− + 
10 − + + /− + 
SNA
Control 0 − + + /− − 
Infected
2 + /− + + /− − 
4 + /− + + − 
Pzq-treated
5 − + + /− − 
6 − + + + /− + 
Reinfected
8 − + + + + /− 
+ 
10 − + + + /− 
Table 1.  Lectin staining, subjectively described from +++ (very strong) to − (absent) in infected, pzq-treated 
and reinfected mice at different weeks post-primary infection (wppi), compared with non-infected controls 
(0 wppi). The staining was independently evaluated in brush border, mucus and goblet cell vesicles. In case that 
both stained and non-stained vesicles were observed, the predominant ones are indicated in the right column. 
When all vesicles showed the same staining pattern this distinction is not applicable (NA). Glycans recognized 
by each lectin are GlcNAcβ 1,4 (WGA), GalNAcα 1,3(LFucα 1,2)Galβ 1,3/4GalNAcβ 1- (DBA),  
α -L-Fucosyl terminals (UEA-I).
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IL-25, the alarmins IL-33 and TSLP are not sufficient to facilitate the development of protective Th2 responses in 
the E. caproni primary infections in ICR mice.
To confirm the crucial role of tuft cells and IL-25 in the generation of Th2 responses in E. caproni infections, 
mice were treated with rIL-25. All rIL-25-treated mice were refractory to infection. Exogenous IL-25 induced tuft 
cell expansion together with a strongly polarized Th2 environment with elevated levels of IL-13. It is well known 
that IL-25 inhibits Th1 differentiation facilitating Th2 differentiation and protecting against intestinal helminth 
infections31,32. Similarly to our results, absence of innate IL-25 expression facilitate chronicity of H. polygyrus 
in mice32. Under these conditions, rIL-25-treated mice were resistant to infection as determined by necropsy 
from 3 days post-primary infection (dppi). The levels of IL-33 and TSLP were not affected by IL-25 treatment, 
confirming the major role of this cytokine in protection against E. caproni infection. Interestingly, metacercariae 
administration to rIL-25-treated mice resulted in a reduction of endogenous IL-25 and IL-13 expression with 
respect to non-exposed rIL-25-treated mice, together with a transient boost of IL-12p35. This confirms that 
E. caproni infection in ICR mice does not activate IL-25 expression but, in contrast, induces IL-12 production 
which may explain the susceptibility to E. caproni primary infection.
Drug cure of primary infection resulted in a sudden decrease in cytokine expression with a concomitant 
overexpression of IL-25 and maintained tuft cell hyperplasia. Although it is difficult to explain the boost of IL-25 
after worm elimination, this may well be related to the restoration of the intestinal epithelium, which is severely 
damaged because of the infection16. Previous studies showed that mechanisms for wound healing and epithelial 
restoration are activated early after E. caproni infection33,34. Our current results support that E. caproni primary 
infection activates several mechanisms to enhance epithelial homeostasis, in response to those processes that 
cause pathology. Although alternative activation of macrophages is common in intestinal helminth infections35,36, 
E. caproni primary infection caused overexpression of markers of both classical (IL-12 and iNOS) and alternative 
(ArgI and Ym-I) activation pathways. Similar to our results, Citrobacter rodentium infection in mice induced 
an intestinal Th1 environment with simultaneous classical and alternative activation of macrophages37. It was 
suggested that upregulation of ArgI was protective by enhancing the generation of polyamines in addition to 
competitive inhibition of iNOS. Modulation of the balance between iNOS and ArgI, and the arginase-ornithine 
decarboxylase metabolic pathway may represent a strategy for regulating intestinal inflammation37. Moreover, 
polyamines and Ym-I are useful for the repair of tissue damage38–40.
However, overproduction of polyamines may contribute to malignancy due to their cell proliferating effect 
and the oxidative stress caused by polyamine oxidase37. These features are consistent with the tissue alterations 
observed in responses to E. caproni infection in mice. E. caproni primary infection induces a pro-tumorigenic 
environment, with intestinal epithelial cell hyper-proliferation and increased epithelial restoration33,34. In this 
context, tuft cell hyperplasia and upregulation of IL-25 may participate in tissue repair after worm clearance. Th2 
Lectin




Goblet cell vesicles Brush 
border Mucus
Goblet cell vesicles
Staining Predominance Staining Predominance
WGA
0 (0) − − − NA − − − NA
2 (0) + /− + + /− + + /− + + /− + 
5 (3) + /− + + + + /− + + + + + /− + 
9 (7) + + /− + + + + + /− + + + /− + + /− − 
16 (14) + /− + + + + /− + + + /− + /− + /− − 
DBA
0 (0) + + + + + + NA + + + + + + NA
2 (0) + + + + + + /− + + + + + + + + /− + 
5 (3) + + + + + + /− + + + + + + + + NA
9 (7) + + + + + + + + + NA + + + + + + + NA
16 (14) + + + + + + /− + + + + + /− + 
UEA-I
0 (0) − + + + NA − + + + NA
2 (0) − + + + + + + /− + + + − + + + + + + /− + + + 
5 (3) − + + + + + + /− + + + − + + /− + + /− + + 
9 (7) − + + + + + + /− + + + + /− + + NA
16 (14) − + + + + + + /− + + + − + + /− − 
SNA
0 (0) − + + /− − − + + /− − 
2 (0) − + + /− − − + + /− − 
5 (3) − + + /− + + /− + + − + /− + /− + /− 
9 (7) − + + /− + + /− + + − + + /− + + /− + + 
16 (14) − + + /− − − + /− + /− − 
Table 2.  Lectin staining, subjectively described from +++ (very strong) to − (absent) in rIL-25-treated and 
rIL-25-treated and infected mice with Echinostoma caproni metacercariae. The staining was independently 
evaluated in brush border, mucus and goblet cell vesicles. In case that both stained and non-stained vesicles 
were observed, the predominant ones are indicated in the right column. When all vesicles showed the 
same staining pattern this distinction is not applicable (NA). dpt: day after starting with intraperitoneal 
administration of IL-25; dppi: day after challenge with Echinostoma caproni metacercariae.
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responses have been found to mediate the acute wound healing in intestinal helminth infections41. Moreover, 
tuft cells have been suggested to play a functional role, which may be critical in the epithelial restorative response 
to injury by activating, via IL-25, ILC2 to secrete IL-13 that acts on epithelial cell progenitors to promote their 
differentiation28,42. This boost of IL-25 induced by the cure of the primary infection may determine resistance 
against secondary infections. Challenge infection in an environment with elevated levels of IL-25 resulted in a 
significantly lower infection rate and worm recovery than in primary infections. Under these conditions, a Th2 
phenotype with elevated levels of IL-4 and IL-13 and downregulation of IL-12p40 and IFN-γ was observed. 
Interestingly, the expression of IL-33 and TSLP was not affected after secondary infections, probably due to the 
lesser tissue damage induced21, which is supported by the low levels of iNOS. Interestingly, metacercariae chal-
lenge of resistant rIL-25-treated mice induced a peak of IL-12p35, though the presence of IL-25 prevented the 
development of a Th1 phenotype as it occurs in primary infections in naïve mice.
Protective type 2 responses against intestinal helminths have been associated with epithelial remodeling medi-
ated by IL-13 and both quantitative and qualitative changes in intestinal mucus, among other mechanisms35,43,44. 
Our results indicate that partial and complete resistance to E. caproni infections are associated with goblet cell 
hyperplasia and changes in mucus glycosylation at the time of challenge infection. Although previous studies 
have suggested that goblet cell hyperplasia has little effect on resistance to E. caproni infections16,45,46, our current 
results are somewhat confusing. Primary infection induced a goblet cell hyperplasia of about 4-fold greater than 
in negative controls from 4 wppi. Cell counts remained elevated until the end of the experiment, concomitantly 
with the development of chronic infections and elevated worm recoveries. After pzq treatment, goblet cell levels 
returned to normal values, and secondary infection induced an earlier but lesser (about 2-fold) goblet cell expan-
sion. Goblet cell hyperplasia appeared earlier in mice partially and completely resistant to infection. Although 
further evidence is needed, the early goblet cell hyperplasia observed in secondary infections and, mainly, in 
rIL-25-treated mice may contribute to resistance by hindering the establishment of newly excysted juvenile 
worms. In contrast, the later response that occurs in primary infections, may allow the development of juvenile to 
adult worms that could be resistant to the rejection-promoting effect of intestinal mucus.
As changes in mucin glycosylation induced by Th2 response have also been related to resistance to intestinal 
helminth infections, we investigated the specific staining of mucins in primary (chronic) infections, secondary 
(partially resistant) infections and resistant rIL-25-treated mice. Partial and complete resistance to infection were 
associated with elevated intensity of staining at the time of infection using WGA and UEA-I lectins. Previous 
studies have suggested that resistance to infection with the related species Echinostoma trivolvis is associated with 
increased expression of GlcNAcβ 1,4 (GlcNAc) residues47. Moreover, elevated levels of GlcNAc and GlcNAcβ 1,4 
(GalNAc) GlcNAcβ 1,4 residues were associated with resistance to superimposed E. caproni infections in rats 
infected with Syphacia muris48. Herein, we have observed that partial and complete resistance to E. caproni infec-
tion occurred when infection took place in an environment with elevated expression of GlcNAc residues as deter-
mined by staining with WGA. However, the results obtained using UEA-I lectin appear to be of more relevance. 
Complete resistance to infection in rIL-25-treated mice was associated with an early enhanced expression of 
Figure 6. Infection and treatment with rIL-25 induce changes in mucin glycosylation. Images of fluorescent 
microscopy of ileal sections from (A) mice infected, praziquantel (pzq)-treated and reinfected with Echinostoma 
caproni and (C,D) rIL-25-treated ICR mice and rIL-25-treated and infected ICR mice with Echinostoma caproni 
stained with WGA, DBA and UEA-I lectins. wppi: weeks post-primary infection; dpt: days after infection. Scale 
bar: 30 μ m.
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terminal α -L-Fucosyl terminals (Fuc) residues in extracellular mucus and goblet cell vesicles, which is induced 
by IL-25 administration prior to infection. It has been shown that fucosylation of the small intestinal epithelium 
in response to infection may constitute a protective mechanism by enhancing host-microbial interactions during 
pathogen–induced stress49,50. Intensity of staining with UEA-I in secondarily infected mice was lower than in 
rIL25-treated mice which might be related to lesser quantity of IL-25 in the environment. Our results also suggest 
that exposure to E. caproni metacercariae regulates the expression of terminal Fuc residues to enhance parasite 
survival. Susceptibility of mice to primary infections was related with downregulation of terminal Fuc residues 
with respect to naïve mice. Moreover, exposure of rIL-25-treated mice to E. caproni metacercariae resulted in 
a marked reduction of the elevated expression of Fuc residues induced after rIL-25 treatment. Although the 
mechanism that determines the reduction of Fuc residues needs to be explored further, this change may serve to 
enhance parasite survival in absence of IL-25 in the milieu.
In summary, although the role of tuft cells and IL-25 in the outcome of intestinal helminth infections has 
been scarcely studied, our results indicate that they play a role in host resistance or susceptibility to infection. 
Susceptibility to primary infections is related to the inability of mice to express IL-25, despite expansion of tuft 
cells lineage. Under these conditions, a Th1 environment is developed, leading to chronic infections. In contrast, 
tuft cell hyperplasia induced by inoculation with exogenous IL-25 or due to epithelial restoration after cure of a 
primary infection enhanced tuft cell expansion and endogenous IL-25 production facilitating the development 
of protective Th2 responses with elevated levels of IL-13. Although the effector mechanisms responsible for the 
resistance need to be studied further, changes in goblet cell populations and increased expression of terminal Fuc 
residues in intestinal mucus appear to be involved in resistance against E. caproni.
Material and Methods
Parasites, hosts and experimental infections. The strain of E. caproni has been described previously47. 
Encysted metacercariae of E. caproni were removed from the kidney and pericardial cavity of experimentally 
infected Biomphalaria glabrata snails and used to infect male ICR mice weighing 30–35 g by gastric gavage 
(50 metacercariae each). The positivity of the infection was determined at necropsy or detection of eggs in stools 
as described previously15.
Ethics Statement. This study has been approved by the Ethical Committee of Animal Welfare and 
Experimentation of the University of Valencia (Ref#A18348501775). Protocols adhered to Spanish (Real Decreto 
53/2013) and European (2010/63/UE) regulations.
Primary and secondary infections. A total of 90 mice were infected and randomly allocated to three 
groups (infected, pzq-treated and reinfected) of 30 mice each. The characteristics of the primary infections were 
studied in the animals in the infected group. These animals were maintained infected without additional treat-
ment until the end of the experiment at 10 weeks post primary infection (wppi). At 4 wppi, animals in the other 
two groups, pzq-treated and reinfected, were treated with a double dose of 100 mg/Kg of praziquantel (pzq), 
orally administered on alternate days as described previously21. All mice belonging to these groups responded to 
the treatment and reverted to negative as determined by coprological examination. Two weeks after treatment, 
all mice in the reinfected group were challenged with 50 metacercariae of E. caproni following the same proce-
dure used in primary infections. At 2, 4, 5, 6, 8, and 10 wppi, 5 animals of each group were necropsied to collect 
the materials required. The experiment was performed once, with 30 mice per group which were assayed as 
5 replicates per each of 6 time points. Moreover, a total of 5 uninfected mice were used as controls at 0 wppi. The 
influence of the pharmacological treatment over the studied parameters was discarded since four additional mice 
were left uninfected, treated with pzq as described above and analyzed as the other animals. All the animals were 
maintained under conventional conditions with food and water ad libitum.
Effect of IL-25 on E. caproni infection. To analyze the effect of IL-25 on the infection, a total of 40 mice 
were intraperitoneally injected with 0.5 μ g of mouse recombinant IL-25 (rIL-25, R&D Systems) in saline buffer 
daily for 5 days and randomly allocated in two groups of 20 mice each: rIL-25-treated and exposed rIL-25-treated 
mice). The second day after starting with rIL-25 administration, animals in the exposed rIL-25-treated group 
were primarily infected with 50 metacercariae each, following the same procedure described above. Additionally, 
5 mice were used as control and were injected with of saline buffer following the same protocol. At 3, 7 and 14 
dppi, 5 the animals of each group were necropsied to determine the worm recovery and obtain the material 
required for the study.
Total RNA extraction. Total RNA was extracted from full-thickness sections of ileum of necropsied mice. 
Total RNA was isolated using Real Total ARN Spin Plus kit (Durviz) according to the manufacturer’s instructions. 
The cDNA was synthesized using High Capacity cDNA Reverse Transcription kit (Applied Biosystems® ).
Real-Time PCR and relative quantification analysis. For quantitative PCR, 40 ng total RNA wasreverse 
transcribed to cDNA and added to 10 μ L of TaqMan® Universal PCR Master Mix, No AmpErase® UNG (2x), 
1 μ L of the specified TaqMan® Gene Expression Assay, and water to a final reaction volume of 20 μ L. Reactions 
were performed on the Abi Prism 7000 (Applied Biosystems®), with the following thermal cycler conditions: 
initial setup of 10 min at 95 °C, and 40 cycles of 15 s denaturation at 95 °C and 1 min of annealing/extention at 
60 °C each. Samples were amplified in a 96-well plate. In each plate, endogenous control, samples and nega-
tive controls were analyzed in triplicate. All TaqMan® Gene Expression primers and probes for inducible nitric 
oxide synthase (iNOS), cytokines and mucins were designed by Applied Biosystems® and offered as Inventoried 
Assays. The assay ID details are shown in Supplementary Table 1. Each assay contains two unlabeled primers and 
one 6-FAM™ dye-labeled, TaqMan® MGB probe. Primer concentration was optimized by a matrix of reactions 
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testing a range of concentrations for each primer against different concentrations of the partner primer and also 
negative controls were included.
Cycle threshold (Ct) value was calculated for each sample, housekeeping and uninfected control. To normalize 
for differences in efficiency of sample extraction or cDNA synthesis we used β -actin as housekeeping gene. To 
estimate the influence of infection in the expression levels we used a comparative quantification method (2−ΔΔCT 
– method)51. This method is based on the fact that the difference in threshold cycles (Δ Ct) between the gene of 
interest and the housekeeping gene is proportional to the relative expression level of the gene of interest. The fold 
change in the target gene was normalized to β -actin and standardized to the expression at time 0 (uninfected 
animals) to generate a relative quantification of the expression levels52.
Analysis of goblet cell responses. Goblet cell responses to E. caproni infections in the ileum of mice 
were evaluated in primary and secondary infections and in rIL-25-treated mice. At each time point, 5 mice in 
each group were necropsied and ileal sections of about 0.7 cm in length were obtained and fixed in 4% para-
formaldehyde (PFA). After embedding in paraffin wax, serial 4 μ m-sections were cut from each tissue block and 
stained with alcian blue. Due to the severe tissue damage induced by primary E. caproni infection, which makes 
it difficult to count the number of cells per villus-crypt unit, results are expressed in number of cells per high 
power field (HPF) (400x), studied over 10 selected HPFs. Results are expressed as the mean number of cells per 
HPF ± standard deviation.
Analysis of tuft cell responses. Tuft cell populations were study using anti-doublecortin-like kinase 
1 (Dclk1) antibody, a molecule that serve as a marker of these cells. Fluorescent immunohistochemistry was 
performed on paraffin-embedded tissue sections, basically as described previously46. Goat antibody anti-Dclk1 
(ab31704, Abcam) was used as primary antibody for staining intestinal tuft cells27. Anti-Dclk1 was diluted 1/1,000 
in PBS containing 0.3% Triton™ X-100 and 10% FCS and incubated for 18 h in a humid chamber at room tem-
perature, under continuous agitation. After washing 3 times in PBS, intestinal sections were incubated for 2 h 
with secondary antibody, goat anti-rabbit IgG conjugated with Alexa Fluor® 647 (Jackson ImmunoResearch 
Laboratories, Inc.), diluted 1/100 in PBS-Triton™ X-100 (0.3%). Slides were washed in PBS and cell nuclei were 
counterstained with DAPI before mounting with Fluoromount™ (Sigma-Aldrich). Cell staining was analyzed by 
fluorescence microscopy. Results are expressed as the mean number of cells per field (200x) ± standard deviation, 
studied over 5 selected fields.
Lectin histochemistry and confocal microscopy. Glycosylation patterns in the ileum of E. caproni- 
infected mice were determined using a lectin-biotin, avidin-peroxidase method on PFA-fixed sections of ileal 
samples, as described previously46. Briefly, tissue sections were deparaffinized and rehydrated. A blocking solution 
of 5% BSA (Roche) and 0.2% Triton™ X-100 (Sigma-Aldrich) in PBS was applied for 1 h. After washing, slides 
were incubated for 1.5 h with a panel of 4 different biotinylated lectins: Dolichos biflorus agglutinin, DBA; 
Ulex europeaus agglutinin, UEA-I; Triticum vulgaris agglutinin, WGA; and Sambucus nigra agglutinin, SNA 
(all of them from Sigma-Aldrich) at proper dilutions in PBS, containing Triton™ X-100 (0.2%). After washing, 
the sections were incubated with the avidin-peroxidase conjugate diluted 1:1,000 in PBS with Triton™ X-100 
(0.2%) for 1 h, followed by repeated washes. Next, the slides were incubated with goat antibody anti-peroxidase, 
conjugated with fluorescein isothiocyanate (FITC) (Jackson InmunoResearch) at a dilution of 1:200 in PBS for 
1 h in darkness. Finally, the sections were counterstained with DAPI and mounted using the Fluoromount™ pro-
cedure. In order to determine potential autofluorescence or unspecific binding, negative controls were used. They 
were processed as described above with the exception of the incubation with lectins. The histological staining was 
evaluated as described previously53 and was ranked using (− ) for absent, (+ ) for just detectable (+ + ) for positive 
and (+ + + ) for strongly positive. The slides were analyzed by multitracking on a FV10I confocal microscope 
(Olympus). A total of 5 intestinal sections were analyzed for each animal at each time point. The assessment of the 
histological staining was carried out blindly.
Statistical analysis. χ 2 test was used to compare the rates of infection between both groups of mice at each 
week post-infection. To compare the worm recovery between primary and challenge infections, a Student’s t-test 
was used at each week post-infection. One-way ANOVA with Bonferroni test as post-hoc analysis were used 
to compare expression levels of cytokines, enzymes, goblet cells and tuft cells at each time point. P < 0.05 was 
considered as significant. Prior to analyses, data were log transformed to achieve normality and verified by the 
Anderson–Darling Test.
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